Pharmacy on Web

3 November 2008

UPDATES
   The first shipment of Goldshield thyroxine has landed in New Zealand at last. Goldshield Thyroxine is the alternative fully subsidised brand to GSK Eltroxin. This has been a hot health issue for the last few months and its great to see that Pharmac has kept their word. Patient who has side effects from Eltroxin, can now try a fully subsidised alternative without financial hindrance.
We received our first batch of Goldshield Thyroxine today and immediately it went out but we have manage to capture a couple of pics.

  The initial batch of Goldshield Thyroxine has a totally different name and manufacturer on the packaging which as added to further confusion but Goldshield Healthcare (NZ) promptly issue a media statement to Pharmacist to clarify the matter.

  Goldshield Healthcare (NZ) Media Release

To View PDF files

You can view this explanation in PDF which will help your understanding of the issue when you pick up your prescription from your local chemist.

In summary the new Goldshield Thyroxine has been named generically as "Levothyroxine" due to legal naming issues with the Eltroxin trademark. The product is manufactured by Forley Generics Ltd which is owned by Goldshield Pharmaceuticals Ltd but future batches will have Goldshield Healthcare (NZ) on it.

Its quite important you read and understand new consumer information for Goldshield Levothyroxine here or access via the Medsafe website

Goldshield Thryoxine Patient Product Information Part ONE

To view PDF files

Goldshield Thryoxine Patient Product Information Part TWO

Please contact Goldshield  Healthcare (NZ) by phone 0800 565 633 or by email This e-mail address is being protected from spambots. You need JavaScript enabled to view it for any information on the product.